PD-1 inhibitor combined with Docetaxel exerts synergistic anti-prostate cancer effect in mice by down-regulating the expression of PI3K/AKT/NFKB-P65/PD-L1 signaling pathway
Zhou, Sixu, Wang, Baogui, Wei, Yingying, Dai, Peiru, Chen, Yan, Xiao, Yingyi, Xia, Hongmei, Chen, Chunlin, Yin, Weihua
Published in Cancer biomarkers : section A of Disease markers (01.01.2024)
Published in Cancer biomarkers : section A of Disease markers (01.01.2024)
Get full text
Journal Article